BioNTech SE ADR sell Snowman
Start price
18.12.20
/
50%
€85.51
Target price
18.12.21
€40.00
Performance (%)
14.23%
End price
09.02.21
€97.68
Summary
This prediction ended on 09.02.21 with a price of €97.68. The prediction closed with a disappointing performance of 14.23%. Snowman has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioNTech SE ADR | 7.896% | 7.896% | 243.124% | - |
| iShares Core DAX® | -1.226% | 2.804% | 14.933% | 16.561% |
| iShares Nasdaq 100 | -1.845% | 2.732% | 26.075% | 54.743% |
| iShares Nikkei 225® | -1.132% | -2.218% | 5.361% | 4.560% |
| iShares S&P 500 | -0.980% | 1.883% | 22.727% | 45.760% |
According to Snowman what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Innovative
Some uniques
Top 10 in its market
Known brand
Cons
overvalued
Below average Management
High risks for its business
Probably not worthwhile Investment
Very high cyclical dependencies
Business model of the past or high risk
Comments by Snowman for this prediction
In the thread Biontech SE diskutieren
Sell mit Kursziel 40,0
In the thread Trading Biontech SE
Stopped prediction by Snowman for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€96.62
05.05.23
05.05.23
€70.00
05.05.24
05.05.24
-11.15%
06.05.24
06.05.24
Innovative
Some uniques
overvalued
Below average Management
BioNTech SE ADR
Start price
Target price
Perf. (%)
€148.75
30.01.22
30.01.22
€110.00
30.01.23
30.01.23
-13.01%
31.01.23
31.01.23
Innovative
Some uniques
overvalued
Below average Management
BioNTech SE ADR
Start price
Target price
Perf. (%)
€204.60
09.11.21
09.11.21
€260.00
09.11.22
09.11.22
-27.30%
30.01.22
30.01.22
Innovative
Some uniques
overvalued
Below average Management